Treatments | Incubation period | Disease incidence (%) | Disease severity (%) |
---|---|---|---|
ARAI 3221 | 35.00 a*− | 0.00 a* | 0.00 a |
ARAC 3221 | 35.00 a*− | 0.00 a* | 0.00 a |
ARAC 2211 | 35.00 a*− | 0.00 a* | 0.00 a |
ARAI 3121 | 35.00 a*− | 0.00 a* | 0.00 a |
ARAI 3312 | 35.00 a*− | 0.00 a* | 0.00 a |
ARTI 3121 | 35.00 a*− | 0.00 a* | 0.00 a |
ARTI 3311 | 35.00 a*− | 0.00 a* | 0.00 a |
ARSI 2112 | 35.00 a*− | 0.00 a* | 0.00 a |
ARSI 1121 | 27.33 ab | 1.70 a | 1.42 ab |
ARAI 1211 | 27.00 ab | 1.52 a | 1.52 ab |
ARTI 1312 | 25.66 ab | 2.83 a | 1.95 ab |
ARAI 3211 | 18.33 bc | 4.23 a | 2.93 ab |
ARSC 2311 | 17.33 bc | 3.53 a | 2.64 ab |
ARTI 3221 | 12.00 cd | 3.80 a | 2.38 ab |
ARTI 3112 | 9.00 cd | 4.67 a | 3.38 ab |
MANKOZEB | 9.00 cd | 12.37 b | 13.07 c |
ARAC 3321 | 8.66 cd | 2.09 a | 5.04 b |
CONTROL− | 4.33 d | 86.15 c | 71.05 d |
Variety coefficient | 5.91 | 19.13 | 16.76 |